Dr. Claudia M. Cooke keeps her Integrative Internal Medicine practice in New York City, and has been prescribing LDN for 20 of those years. Dr. Cooke had the privilege of sitting in with Dr. Bernard Bihari in his clinic on a couple of occasions, reviewing patients with him. Dr. Bihari, one of the early clinical research pioneers in the broad application of low dose naltrexone, is generally well known to the LDN community.
Bernard Bihari, MD, was one of the early clinical research pioneers in the broad application of low dose naltrexone. Dr. Cooke had the privilege of sitting with him in his office on two occasions and consulting with him many times by telephone, asking lots of questions, sharing clinical observations, in those early years of using LDN. His generosity of spirit is fondly remembered.
Dr. Cooke’s use of LDN includes chronic viral illnesses, autoimmune diseases, multiple sclerosis, cancer, and more recently, as an adjunct in therapy for tick-borne diseases. The results have been largely gratifying, and she considers it a great boon to the management of many of our chronic illnesses.
Remote appointments may be booked through her front desk, 212-213-0288, and complexity of presentation will dictate fees. Some preliminary paperwork is required prior to appointment. Additionally, a CBC/differential panel within one month of the appointment is required for prescription. NK cell panel is desirable but not strictly required.